The effect of intraoperative fluid administration on outcomes of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy | Zendy

Raphael Shamavonian | Zendy; Rohan McLachlan | Zendy; Oliver M. Fisher | Zendy; Sarah J. Valle | Zendy; Nayef Alzahrani | Zendy; Winston Liauw | Zendy; David L. Morris | Zendy

Open Access

The effect of intraoperative fluid administration on outcomes of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy

Author(s) -

Raphael Shamavonian,

Rohan McLachlan,

Oliver M. Fisher,

Sarah J. Valle,

Nayef Alzahrani,

Winston Liauw,

David L. Morris

Publication year - 2019

Publication title -

journal of gastrointestinal oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.084

H-Index - 39

eISSN - 2219-679X

pISSN - 2078-6891

DOI - 10.21037/jgo.2018.12.11

Subject(s) - medicine , hyperthermic intraperitoneal chemotherapy , cytoreductive surgery , blood product , intensive care unit , blood transfusion , surgery , retrospective cohort study , cohort , chemotherapy , anesthesia , cancer , ovarian cancer

Determine the effect of intraoperative fluids (IOFs) administered during cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) on postoperative patient outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research